Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1995 Apr 22;310(6986):1037–1040. doi: 10.1136/bmj.310.6986.1037

Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth.

R E Gilbert 1, M R Stanford 1, H Jackson 1, R E Holliman 1, M D Sanders 1
PMCID: PMC2549430  PMID: 7728057

Abstract

OBJECTIVE--To determine the incidence of acute symptomatic toxoplasma retinochoroiditis presenting to ophthalmologists for patients born in Britain and elsewhere. DESIGN--Population based, cross sectional study. SETTING--11 districts in south Greater London. SUBJECTS--All patients presenting to NHS ophthalmologists with symptoms due to acute toxoplasma retinochoroiditis in 1992-3. MAIN OUTCOME MEASURE--Intraocular inflammation in association with a retinochoroidal scar, active adjoining retinitis, and IgG serum antibodies to toxoplasma. RESULTS--The estimated incidence of acute symptomatic retinochoroiditis for all people born in Britain was 0.4/100,000/year. If a mean of two symptomatic episodes per lifetime is assumed, 100 people born in Britain may be affected each year, about a fifth of the estimated 500-600 congenitally infected people born each year. CONCLUSIONS--A substantial proportion of people with acute symptomatic toxoplasma retinochoroiditis were born outside the country, and the number born in Britain was smaller than the number previously estimated to develop retinochoroidal lesions due to congenital toxoplasmosis. These findings suggest that prenatal screening for toxoplasmosis in Britain may be of limited benefit.

Full text

PDF
1037

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect. 1992 Apr;108(2):367–375. doi: 10.1017/s0950268800049839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ades A. E., Nokes D. J. Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. Am J Epidemiol. 1993 May 1;137(9):1022–1034. doi: 10.1093/oxfordjournals.aje.a116758. [DOI] [PubMed] [Google Scholar]
  3. Berrebi A., Kobuch W. E., Bessieres M. H., Bloom M. C., Rolland M., Sarramon M. F., Roques C., Fournié A. Termination of pregnancy for maternal toxoplasmosis. Lancet. 1994 Jul 2;344(8914):36–39. doi: 10.1016/s0140-6736(94)91054-5. [DOI] [PubMed] [Google Scholar]
  4. Chesterton J. R., Perkins E. S. Ocular toxoplasmosis among Negro immigrants in London. Br J Ophthalmol. 1967 Sep;51(9):617–621. doi: 10.1136/bjo.51.9.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Conyn-van Spaendonck M. A. Prevention of congenital toxoplasmosis; experience in The Netherlands. Int Ophthalmol. 1989 Dec;13(6):403–406. doi: 10.1007/BF02306489. [DOI] [PubMed] [Google Scholar]
  6. Desmonts G., Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974 May 16;290(20):1110–1116. doi: 10.1056/NEJM197405162902003. [DOI] [PubMed] [Google Scholar]
  7. Fathy V. C., Elton P. J. Orthoptic screening for three- and four-year-olds. Public Health. 1993 Jan;107(1):19–23. doi: 10.1016/s0033-3506(05)80488-3. [DOI] [PubMed] [Google Scholar]
  8. Friedmann C. T., Knox D. L. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969 Apr;81(4):481–493. doi: 10.1001/archopht.1969.00990010483005. [DOI] [PubMed] [Google Scholar]
  9. Gilbert R. E., Tookey P. A., Cubitt W. D., Ades A. E., Masters J., Peckham C. S. Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ. 1993 Jan 16;306(6871):185–185. doi: 10.1136/bmj.306.6871.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Glasner P. D., Silveira C., Kruszon-Moran D., Martins M. C., Burnier Júnior M., Silveira S., Camargo M. E., Nussenblatt R. B., Kaslow R. A., Belfort Júnior R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992 Aug 15;114(2):136–144. doi: 10.1016/s0002-9394(14)73976-5. [DOI] [PubMed] [Google Scholar]
  11. Guerina N. G., Hsu H. W., Meissner H. C., Maguire J. H., Lynfield R., Stechenberg B., Abroms I., Pasternack M. S., Hoff R., Eaton R. B. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994 Jun 30;330(26):1858–1863. doi: 10.1056/NEJM199406303302604. [DOI] [PubMed] [Google Scholar]
  12. Hall S. M. Congenital toxoplasmosis. BMJ. 1992 Aug 1;305(6848):291–297. doi: 10.1136/bmj.305.6848.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hartup C., Johnson J. D., Holliman R. E. Medical audit of the investigation of toxoplasmosis associated with pregnancy. Lancet. 1992 Jul 11;340(8811):118–119. doi: 10.1016/0140-6736(92)90444-8. [DOI] [PubMed] [Google Scholar]
  14. Joss A. W., Chatterton J. M., Ho-Yen D. O. Congenital toxoplasmosis: to screen or not to screen? Public Health. 1990 Jan;104(1):9–20. doi: 10.1016/s0033-3506(05)80340-3. [DOI] [PubMed] [Google Scholar]
  15. Joss A. W., Skinner L. J., Chatterton J. M., Chisholm S. M., Williams H. D., Ho-Yen D. O. Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection. Public Health. 1988 Sep;102(5):409–417. doi: 10.1016/s0033-3506(88)80078-7. [DOI] [PubMed] [Google Scholar]
  16. Joynson D. H., Payne R. Screening for toxoplasma in pregnancy. Lancet. 1988 Oct 1;2(8614):795–796. doi: 10.1016/s0140-6736(88)92443-9. [DOI] [PubMed] [Google Scholar]
  17. Koppe J. G., Rothova A. Congenital toxoplasmosis. A long-term follow-up of 20 years. Int Ophthalmol. 1989 Dec;13(6):387–390. doi: 10.1007/BF02306486. [DOI] [PubMed] [Google Scholar]
  18. Lakhanpal V., Schocket S. S., Nirankari V. S. Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol. 1983 May;95(5):605–613. doi: 10.1016/0002-9394(83)90378-1. [DOI] [PubMed] [Google Scholar]
  19. Nokes D. J., Forsgren M., Gille E., Ljungström I. Modelling toxoplasma incidence from longitudinal seroprevalence in Stockholm, Sweden. Parasitology. 1993 Jul;107(Pt 1):33–40. doi: 10.1017/s0031182000079373. [DOI] [PubMed] [Google Scholar]
  20. Perkins E. S. Ocular toxoplasmosis. Br J Ophthalmol. 1973 Jan;57(1):1–17. doi: 10.1136/bjo.57.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Prenatal management and congenital toxoplasmosis. N Engl J Med. 1988 Aug 11;319(6):372–374. doi: 10.1056/NEJM198808113190615. [DOI] [PubMed] [Google Scholar]
  22. Preventing congenital toxoplasmosis. Lancet. 1990 Oct 20;336(8721):1017–1018. [PubMed] [Google Scholar]
  23. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 1993 Jun;77(6):371–377. doi: 10.1136/bjo.77.6.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Silveira C., Belfort R., Jr, Burnier M., Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 1988 Sep 15;106(3):362–364. doi: 10.1016/0002-9394(88)90382-0. [DOI] [PubMed] [Google Scholar]
  25. Stagno S., Dykes A. C., Amos C. S., Head R. A., Juranek D. D., Walls K. An outbreak of toxoplasmosis linked to cats. Pediatrics. 1980 Apr;65(4):706–712. [PubMed] [Google Scholar]
  26. Williams K. A., Scott J. M., Macfarlane D. E., Williamson J. M., Elias-Jones T. F., Williams H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect. 1981 Sep;3(3):219–229. doi: 10.1016/s0163-4453(81)90773-8. [DOI] [PubMed] [Google Scholar]
  27. Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES